Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiyin Lin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Retrovirology|May 22, 2024
HIV-1 with gag processing defects activates cGAS sensingRebecca P Sumner, Henry Blest, Meiyin Lin, et al.
Journal of Chemical Information and Modeling|February 23, 2019
Discovering Putative Protein Targets of Small Molecules: A Study of the p53 Activator NutlinMinh N Nguyen, Neeladri Sen, Meiyin Lin, et al.
RSC Advances|February 6, 2026
Synergistic NIR-polydopamine nanotherapy for blood-brain barrier crossing and Parkinson's disease interventionXueer Xia, Jianbang Han, Meiyin Lin, et al.
Immunotherapy Advances|August 28, 2023
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole bloodMeiyin Lin, Sebastian Chakrit Bhakdi, Damien Tan, et al.
Cancer Epidemiology|January 4, 2026
Early-life tobacco exposure, genetic susceptibility and incident colorectal cancer risk in UK biobank: A prospective cohort analysisYu Long, Yuting Zhu, Meiyin Lin, et al.
Advanced Healthcare Materials|January 10, 2025
Three-Level Nanoparticle Rocket Strategy for Colorectal Cancer Therapeutics in Photothermal Therapy, Inflammation Modulation, and Cuproptosis InductionWenting Shang, Xueer Xia, Yuting Zhu, et al.
Hepatology (Baltimore, Md.)|November 29, 2020
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant PatientsMorteza Hafezi, Meiyin Lin, Adeline Chia, et al.
PLOS Digital Health|April 20, 2026
Clinician-deployable deep hypergraph model integrating clinical and CT radiomics predicts immunotherapy outcomes in NSCLCJiangdian Song, Qiang Nie, Siqi Wang, et al.
Nature|July 16, 2020
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNina Le Bert, Anthony T Tan, Kamini Kunasegaran, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Retrovirology|May 22, 2024
HIV-1 with gag processing defects activates cGAS sensingRebecca P Sumner, Henry Blest, Meiyin Lin, et al.
Journal of Chemical Information and Modeling|February 23, 2019
Discovering Putative Protein Targets of Small Molecules: A Study of the p53 Activator NutlinMinh N Nguyen, Neeladri Sen, Meiyin Lin, et al.
RSC Advances|February 6, 2026
Synergistic NIR-polydopamine nanotherapy for blood-brain barrier crossing and Parkinson's disease interventionXueer Xia, Jianbang Han, Meiyin Lin, et al.
Immunotherapy Advances|August 28, 2023
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole bloodMeiyin Lin, Sebastian Chakrit Bhakdi, Damien Tan, et al.
Cancer Epidemiology|January 4, 2026
Early-life tobacco exposure, genetic susceptibility and incident colorectal cancer risk in UK biobank: A prospective cohort analysisYu Long, Yuting Zhu, Meiyin Lin, et al.
Advanced Healthcare Materials|January 10, 2025
Three-Level Nanoparticle Rocket Strategy for Colorectal Cancer Therapeutics in Photothermal Therapy, Inflammation Modulation, and Cuproptosis InductionWenting Shang, Xueer Xia, Yuting Zhu, et al.
Hepatology (Baltimore, Md.)|November 29, 2020
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant PatientsMorteza Hafezi, Meiyin Lin, Adeline Chia, et al.
PLOS Digital Health|April 20, 2026
Clinician-deployable deep hypergraph model integrating clinical and CT radiomics predicts immunotherapy outcomes in NSCLCJiangdian Song, Qiang Nie, Siqi Wang, et al.
Nature|July 16, 2020
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsNina Le Bert, Anthony T Tan, Kamini Kunasegaran, et al.
Pageof 1